for the Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group.Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study) : a multicentre, randomised, double-blind, placebo-controlled trial.

for the Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group.Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study) : a multicentre, randomised, double-blind, placebo-controlled trial.
复制标题

日本 SBMA TAP-144-SR 介入试验 (JASMITT) 研究组。亮丙瑞林对脊髓和延髓肌萎缩患者的疗效和安全性(JASMITT 研究):一项多中心、随机、双盲、安慰剂对照试验。

DOI:
--
复制
发表时间:
2010
期刊:
Lancet Neurol. 9
影响因子:
--
通讯作者:
Tsujino A
Tsujino A
中科院分区:
--
文献类型:
--
作者:
Katsuno M;Banno H;Suzuki K;Takeuchi Y;Kawashima M;Yabe I;Sasaki H;Aoki M;Morita M;Nakano I;Kanai K;Ito S;Ishikawa K;Mizusawa H;Yamamoto T;Tsuji S;Hasegawa K;Shimohata T;Nishizawa M;Miyajima H;Kanda F;Watanabe Y;Nakashima K;Tsujino A

文献摘要

相似文献